The promise of personalized medicine is a world in which interventions, screening, and therapeutics are targeted to those most likely to get the disease. Polygenic risk scores will help society reach this ambition by accurately assessing the contribution that one’s DNA makes to disease risk. When Thomas Jefferson wrote in the Declaration of Independence that ‘all men are created equal,’ he captured the essential concept of equality on which the US Constitution is based. Although no one would
Read More
COTA Promotes Miruna Sasu to President and CEO
What You Should Know: - COTA, Inc., an oncology real-world data and analytics company, announced today that Miruna Sasu, Ph.D., MBA, has been appointed president and chief executive officer. - Since April 2021 when she was hired as the company’s chief strategy officer, Miruna has helped spearhead a series of research collaborations focused on investigating racial disparities in cancer care and the drug development process, including partnerships with the University of Chicago
Read More
Eko Unveils Newly Designed Heart Disease Detection App
What You Should Know: - Eko, a digital health company advancing heart and lung disease detection, today announced the launch of its newly-redesigned Eko App, which will transform patient interactions into an opportunity to screen for cardiovascular disease. Heart disease is the leading cause of death in the U.S., and there has not been an efficient and affordable solution to screen for heart disease at the physical exam until now. - Eko has transformed the traditional stethoscope into an
Read More
Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare/AliveCor Integration
Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the acquisition of DIABNEXT, a Paris-based company whose digital health platform helps people with diabetes better manage their conditions and connects to their healthcare providers, so they can
Read More
Sirona Medical Acquires Nines Radiology AI Division
What You Should Know: - Sirona Medical, a software company with a cloud-native solution for radiologists, has announced its acquisition of Nines Radiology’s AI division. Sirona Medical did not acquire Nines' teleradiology business, Nines Radiology. The terms of the deal were not disclosed. - This is Sirona’s first acquisition just months after its exit from stealth in Aug. 2021 with a total of $62.5M in Series A & B financing rounds. Why It Matters The FDA-cleared medical
Read More
TytoCare Receives CE Mark Approval for its Lung Sounds Analyzer
What You Should Know: - TytoCare has received CE Mark approval for its AI-backed Tyto Lung Sounds Analyzer, a web-based software system designed to aid in the clinical assessment of lung auscultation sound data by analyzing recorded lung sounds to determine whether wheezing is detected within the recording. - The Lung Sounds Analyzer will further enable physicians to better diagnose respiratory conditions remotely. The CE Mark paves the way for the immediate European
Read More
Respira Launches AI Wearable for Lung Function for COPD, COVID, Asthma
What You Should Know: - Today, Respira is introducing its AI wearable technology to monitor for certain very serious lung conditions. According to the Institute for Health Metrics and Evaluation, COPD (Chronic Obstructive Pulmonary Disease) and COVID-19 were the 3rd and 4th global causes of death during the height of the pandemic. Asthma, according to the World Health Organization, is the most common chronic disease among children. - Chest wearable uses tiny speakers and microphones to
Read More
Optellum, Johnson & Johnson Collaborate on AI-Powered Lung-Health Initiative
What You Should Know: - Optellum, a lung-health medtech startup that is pioneering the use of AI to improve diagnostic accuracy and clinical decision-making announce a strategic collaboration with Johnson & Johnson’s Lung Cancer Initiative. This announcement accelerates Optellum’s market entry, building on its FDA clearance earlier this year and deployments underway at hospitals in the USA and ongoing clinical trials in the United Kingdom. - As part of the collaboration, Optellum will
Read More
To Advance Health Equity, Put Real-World Cancer Data to Work
Despite decades of scientific progress against cancer, access to treatment remains highly unequal. Some of the reasons — like institutional racism and poverty — are a reflection of our broader society. Other inequities may go unrecognized but are no less damaging. People with underlying health conditions, for example, may be excluded from clinical trials, preventing them from accessing leading-edge treatments and limiting the evidence available to guide their care. With multiple drivers of
Read More
Tyto Care Launches FDA-Cleared Fingertip Pulse Oximeter Medical Device
What You Should Know: - Tyto Care announces the launch of its fingertip Pulse
Oximeter device, allowing users to measure their own blood oxygen saturation
level and heart rate from the comfort and safety of home. - Expanding its clinic-quality remote capabilities, TytoCare users will be able to perform a remote blood oxygen exam, allowing clinicians to better monitor patients with COVID-19 and chronic lung or heart conditions. Tyto Care, a New York City-based all-in-one modular
Read More
